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Summary 
To gain insight into the mechanism and limitations of antibody affinity maturation leading to 
memory B cell formation, we generated a phage display library of random mutants at heavy 
chain variable  (V)  complementarity determining region 2 positions 58  and 59  of an anti-p- 
azophenylarsonate (Ars) Fab. Single amino acid substitutions at these positions resulting from 
somatic hypermutation are recurrent products of affinity maturation in vivo. Most of the ex 
vivo mutants retained specificity for Ars. Among the many mutants displaying high Ars-binding 
activity,  only one contained a position 58 and 59 amino acid combination that has been previ- 
ously observed among monoclonal antibodies (mAbs) derived from Ars-immunized mice. Affinity 
measurements on 14 of the ex vivo mutants with high Ars-binding activity showed that 11 had 
higher intrinsic affinities for Ars than the wild-type V region. However, nine of these Fabs also 
bound strongly to denatured DNA, a property neither displayed by the wild-type V region nor 
observed among the mutants characteristic  of in vivo affinity maturation. These data suggest 
that ex vivo enhancement of mAb affinity via site-directed and random mutagenesis approaches 
may often lead to a reduction in antibody specificity that could complicate the use of the resulting 
mAbs for diagnostic and therapeutic applications.  Moreover, the data are compatible with a hy- 
pothesis proposing that increased specificity for antigen, rather than affinity per se, is the driving 
force for formation of the memory B cell compartment. 
D 
uring the course of a T cell-dependent antibody response, 
the V regions of antibodies expressed by B cells differen- 
tiating to memory are structurally altered because of hyper- 
mutation of the genes encoding them. Working in concert 
with hypermutation, a stringent process of antigen selection 
results in the affinity maturation of the antibody response. 
Frequent end products of the mutation-selection process are 
V regions containing recurrent amino acid changes at partic- 
ular positions (1-3).  Site-directed  mutagenesis studies have 
shown that many of these recurrent mutations individually 
result in increased  affinity  for the eliciting antigen (2-4). 
Affinity for antigen is only one of the factors that could 
influence the composition of the somatically mutated anti- 
body repertoire expressed by the memory B cell compart- 
ment, however. Somatic mutation takes place throughout the 
length of V region genes, but is not a random process; hot- 
spots and hot areas for mutation clearly exist  (1, 5-7).  In 
some responses, mutants with altered idiotypy (8) or antigen 
binding on-rate (9) may be differentially selected. It has also 
been suggested that somatic mutation will create autoanti- 
bodies de novo (10-13), and that peripheral tolerance mecha- 
nisms must eliminate B cells expressing these autoreactive 
antibodies (14). 
Secondary anti-p-azophenylarsonate (Ars)  1 antibodies from 
A/J mice are largely encoded by a single combination of V 
gene segments (termed "canonical"). Recurrent amino acid 
substitutions due to somatic mutation are observed alone or 
together among these antibodies at  two positions in VH 
CDR2:Thr-58 -~ Ile, and Lys-59 --" Thr (based on an anti- 
body sample representing >35 independent events; references 
1, 15). These mutations individually and additively result in 
increased affinity for Ars, and they account for most of the 
affinity increase displayed by secondary anti-Ars  antibodies 
(4). A high resolution x-ray crystal structure of a canonical 
anti-Ars  antibody suggests that VH residues  58 and 59 are 
not Ars contact residues  (16) and so must alter affinity in- 
1  Abbreviations used in this paper: Ars, p-azophenylarsonate;  Ars-Tyr, Ars- 
N-acetyl-t-tyrosine; cplII, coat protein III; PC, phosphorylcholine. 
743  J. Exp. Med. ￿9  The Rockefeller  University  Press ￿9 0022-1007/95/09/0743/08  $2.00 
Volume 182  September  1995  743-750 directly. To test whether the recurrent nature of the Thr-58 
"* lie and Lys-59 "* Thr amino acid substitutions is due 
entirely to the action of antigen affinity-based positive selec- 
tion, libraries of a canonical antibody Fab that contain random 
amino acid substitutions at Vr~ positions 58  and 59  were 
generated. 
Materials  and Methods 
Construction of  Phage Display  Fab Mutant Libraries.  The pComb3 
Fab expression vector (17) was modified via standard techniques 
to include a chloramphenicol resistance gene and to allow "drop 
in" cloning of V. region PCR products, all as illustrated in Fig. 
1. Site-directed, oligonucleotide-templated, PCR-based mutagen- 
esis of Vrt codons 58 and 59 was carried out as described (18) with 
the modification that Pyrococcusfuriosus  (Pfu) (Stratagene, La  Jolla, 
CA) or Vent (New England Biolabs, Inc., Beverly,  MA) thermosta- 
bile DNA polymerases  were used. To generate more defined  muta- 
tions, a primer containing the 58 and 59 antisense sequence CNT 
AAT (sense = ATT ANG) was used. The resulting plasmids were 
transformed into XL1-Blue (Stratagene), and colonies that grew 
on chloramphenicol  phtes were purified. Single  colonies  were picked 
into 96-well dishes containing luria broth. Replicas of these stock 
plates were created by inoculation into superbroth and were grown 
at 370C to an ODsgs of 0.3, induced with 1 mM isopropyl 3-D- 
thiogalactoside, superinfected with R408 phage at a multiplicity 
of infection of 10, and incubated for 18-36 h at 37~ 
ELISA  Screening and Nucleotide Sequencing of Antibodyphage 
Clones.  Supematants  obtained  from  superinfected phagemid- 
containing bacterial  colonies  were screened  by direct binding ELISA 
assays using 96-well plates (Immulon-4;  Dynatech Laboratories, Inc., 
Chantilly, VA) coated with either Ars-BSA, a rat anti-mouse  K 
chain mAb, or the monoclonal antiidiotypic antibody E4. Bound 
antibody-phage were detected using a sheep anti-M13 antiserum 
(5 Prime ~  3 Prime, Inc., Boulder, CO), followed by an alkaline 
phosphatase conjugate of a donkey anti-sheep Ig antiserum (The 
Binding Site, Inc., San Diego, CA). Plates were developed with 
p-nitrophenylphosphate and read on an ELISA plate reader at 405 
nM. Supernatants obtained from superinfection of colonies con- 
taining the wild-type phagemid and a phagemid containing a VH 
frameshift mutation were used as positive and negative controls 
on every plate. 
The VH and x chain V region (V,) genes present in various 
phagemids were asymmetrically  PCR amplified and sequenced  by 
a modification  of  the dideoxynucleotide  chain termination method 
using Taq DNA polymerase (19). 
Expression, Characterization,  and Purification of  Fabs.  Phagemids 
from the libraries were modified to allow the expression of free 
Fabs. The cplII sequences were deleted as described (17) and illus- 
trated in Fig. 1, and the modified  phagemids were transformed into 
XL1-Blue. The transformants were grown in 2x YT (1.6% tryp- 
tone, 1% yeast extract, 0.5% sodium chloride, 0.2% glycerol, 50 
mM potassium phosphate, pH 7.2) at 30~  to an ODsgs of 0.1, 
induced with 1 mM isopropyl  ~-D-thiogalactoside, and further in- 
cubated for 18-36 h. Periplasmic contents were extracted as de- 
scribed (20). Fabs  were affinity  purified  by chromatography on Ars- 
bovine gamma globulin Sepharose 4B (Pharmacia Biotech, Inc., 
Piscataway, NJ) as previously  described (21). Representative  prepa- 
rations of affinity-purified  Fabs were analyzed for purity on dena- 
turing PAGE. Preparations  were also analyzed  by quantitative  ELISA 
on Ars-BSA, rat anti-g, or E4 plates before further use. 
Measurement  o.f  Ars Affinity and DNA Binding.  Purified  Fabs were 
used in fluorescence  quenching analyses  with Ars-N-acetyl-L-tyrosine 
(Ars-Tyr) as previously  described (22). Association constants were 
calculated by fitting the data to the equation y  =  ax/(1  +  bx). 
The difference  between the measured and calculated quench values 
was minimized with a reiterative method programmed in Excel 
(Microsoft, Inc., Redmond, WA). DNA binding was assayed  by 
direct binding ELISA  essentially  as described  (23) using a biotinylated 
form of  the monoclonal  rat anti-g antibody,  followed  by streptavidin- 
alkaline phosphatase (Sigma Chemical Co., St. Louis, MO). Fabs 
that gave significant signals at 10/zg/ml (relative to plates coated 
without DNA) were further analyzed.  Binding to plate-immobilized 
heat-denatured calf thymus or mouse spleen DNA was competed 
with either soluble heat-denatured DNA, total yeast RNA, B cell 
hybridoma native DNA, or Ars-Tyr at various concentrations. 
Computer Modeling and Graphics.  The program Sybyl (Tripos 
Associates, St. Louis, MO) was used to generate graphic images 
of the 36-71 combining site using an Indigo 2 workstation (Silicon 
Graphics, Mountain View, CA) and coordinates deposited in the 
Brookhaven Protein Data Bank (Brookhaven National Laborato- 
ries, Upton, NY). The arsonate hapten was located in this binding 
site using the docking and energy minimization facilities  of Sybyl, 
in accordance with a previously published model (16). Particular 
attention was paid to the hydrogen bond interactions with Arg- 
96L, Asn-35H, and Ser-99H. In addition, in the deposited coor- 
dinates, an Ala rather than a Thr was built at VH position 59 be- 
cause of truncated side-chain  density. Since  Thr is the residue  found 
at this position in the 36-71 sequence, the Ala side  chain was replaced 
with the Thr side chain followed  by local  energy minimization  using 
Sybyl. 
Results 
As illustrated in Fig. 1, the phagemid vector pCombfabl0 
was constructed from the expression vector pComb3, previ- 
ously described  by Barbas  et al. (17), which allows expres- 
sion of an antibody Fab on the surface of filamentous phage 
(antibodyphage) in the form of a fusion to coat protein III 
(cplII).  RNA from hybridoma BH-3H, which expresses a 
canonical IgG1, was used as a source of coding sequence for 
a canonical Fab (VH-CHI:V,-C,).  The V region of BH-3H 
lacks somatic mutations and contains the most common single 
VH-D  (His) and D-JH (Tyr)junctional amino acids found 
among canonical antibodies (24). 
Restriction sites introduced at the ends of VH coding se- 
quence in the pCombfabl0 vector allowed oligonucleotide- 
directed PCR mutagenesis of VH codons 58 and 59. To con- 
trol for possible artifacts due to bacterial expression  of Fabs, 
we generated several defined mutations at 58 and 59. Subse- 
quently, the cplII sequences were deleted, allowing expres- 
sion of free Fab molecules. Fabs were purified from periplasmic 
preparations by Ars affinity chromatography, and their in- 
trinsic affinities for Ars-Tyr were determined. The values ob- 
tained for the Thr-Lys (wild type), Ile-Lys, and Ile-Thr (pre- 
dominant in vivo)  mutants were in good agreement with 
those obtained for site-directed  mutants of a canonical V re- 
gion expressed as complete antibodies in hybridomas (4, 21). 
VH codons 58 and 59 were "randomized" in pCombfabl0 
in two independent experiments (see Fig.  1 and Materials 
and Methods). A total of  480 colonies picked from the libraries 
were superinfected with helper phage, and supernatants were 
744  Afhnity  Maturation and Autoreactivity Figure  1.  Construction of pCombfabl0 and the 
VH position 58 and 59 random libraries. A V~ (check- 
ered boxes)-C~ (cross-hatched  boxes) cDNA obtained by 
reverse transcription-PCR from hybridoma BH-3H 
RNA was cloned between the Sad (A) and XbaI (B) 
sites of pComb3, resulting in an in-frame fusion with 
one pel B leader region (stippled boxes). The germline 
sequence of V~-C~ and in-frame fusion to pel B was 
confirmed by nucleotide  sequencing. The resulting 
plasmid was modified by insertion of the pBR325 
chloramphenicol resistance  gene (0) in the Nhd (N) 
site, allowing selection against frequent deletions be- 
tween the duplicated lac promotor (filled triangles)/pel 
B leader regions. A VH (horizontally  striped boxes)-CH1 
(vertically striped boxes) IgG1 cDNA obtained by re- 
verse transcription-PCR  from BH-3H RNA was then 
cloned between the XhoI (X) and SpeI (S) sites of 
pComb3, resulting in in-frame fusions with one pel 
B leader and the cplII gene (open boxes). PCR-based 
site-directed mutagenesis procedures were used to in- 
sert unique Sill (F) and Xhol (X) sites at the 5' and 
3' ends of VH,  respectively, and to  replace amino- 
terminal VH codons present in pComb3 with those found in canonical VH genes. An internal deletion of 74 bp in VH was then made to ultimately 
allow distinction between wild-type and mutant clones. The BH-3H VH-CH1 cDNA/pel B leader region containing plasmid pVH41 was used as a 
template for oligonucleotide-directed PCR mutagenesis of VH codons 58 and 59 with an oligonucleotide containing equimolar amounts of each base 
at all six positions of these two codons (N6).  Pfu and Vent thermostabile DNA polymerases were used for this purpose in two separate experiments. 
The resulting populations  of PCR products were used to replace the VH sequences between the Sill (F) and XhoI (X) sites of pCombfabl0. Bacterial 
colonies containing the resulting members of the 58 and 59 random libraries were superinfected with P,408 phage, resulting in the production of 
the mutant Fabs in the form of antibodyphage.  Subsequently, individual members of the libraries were modified by deletion  of the cplII sequences 
between the SpeI (S) and NheI (N) sites, allowing expression of the mutant Fabs as free proteins. 
collected for ELISA assay. To assess for dimerization of V~- 
CHl-cplII  with V~-C~,  a monoclonal  anti-C~  capture  anti- 
body was used.  To more specifically  assess the structure of 
the V domain, the monoclonal antiidiotypic antibody E4 was 
used. Ars-binding activity of the antibodyphage was assessed 
using  Ars-BSA.  Repeated  helper phage  superinfection  and 
ELISA screening  of both libraries yielded reproducible results. 
The vast  majority of the antibodyphage  clones gave  rise 
to significant  signals  in all three ELISA  assays (K +  E4 +  Ars +, 
Fig.  2).  Thus,  most  of the Fabs were expressed  in a native 
state and retained specificity for Ars. Nevertheless, some vari- 
ation in levels  of expression  was  apparent,  so  the levels  of 
anti-g-binding  activity were used to normalize the E4 and 
Ars values. 33 antibodyphage that displayed high Ars/K ratios 
(i.e., the highest apparent Ars affinities) were chosen for nucleo- 
tide  sequencing  analysis.  Since  only  a  few  copies  of the 
Fab-cplII  fusion protein are present at the tip of each phage 
particle  (17), the values  obtained from the ELISA  assays are 
probably directly related to the a~nity of the interaction be- 
tween the Fabs and  the plate-bound  ligands.  A  number of 
the rare mutants that displayed either no anti-g signal or anti-g 
signals but no E4 or Ars reactivity  were also sequenced.  Most 
of the former were found to contain termination codons at 
positions  58  or  59  (data  not  shown). 
The  g+E4-Ars-  and  g+E4+Ars -  clones contain a high 
frequency of Cys codons, or a high frequency of Pro and Gly 
Figure 2.  Representative ELISA screening data ob- 
tained from one of the VH 58 and 59 antibodyphage 
random libraries. Culture supernatants were obtained 
and assayed by ELISA as described in Materials and 
Methods.  Controls included were supernatants  ob- 
tained  from  the  wild-type  clone  that  encodes  a 
K+E4+Ars  + Fab; a mutant containing  an amber ter- 
mination codon in VH  (K-,E4-Ars-; second from 
/eft); a mutant containing six mutations distributed 
throughout VH  (~+E4-Ars-;  third from  /eft); and 
a  mutant containing a  frameshift  mutation in VH 
(K-E4-Ars-; fourth from left). Data obtained from in- 
dividual members of the random library are plotted 
as single vertical  bars in order of  increasing anti-~ signal 
intensity from left to right, after the four controls. 
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Idiotypic and Ars Binding Activity 
58 + 59  Residues  58 + 59  Residues 
K+, E4-,  Ars-  K  +,  E4 §  Ars §  (high  Ars/K ratio) 
Val-Cys  Arg-Arg (5) 
Ile-Cys  Arg-Thr (3) 
Gly-Gly  Arg-Ser (3) 
Glu-Pro  Thr-Lys*  (wild  type; 3) 
Cys-Ser  Leu-Thr (3) 
Arg-Cys  Arg-Gly (2) 
K  +,  E4 §  Ars-  Pro-Arg (2) 
Lys-Arg 
Pro-Cys (2)  Asp-Arg 
Pro-Gly (2)  Ser-Arg 
Gly-Gln  Arg-Leu 
Leu-Asp  Arg-lle 
Ala-Asp  Arg-Lys 
Asp-Gly  Leu-Asn 
Ile-Pro  Tyr-Thr 
Gly-Cys  Thr-Thr* 
Tyr-Pro  Ala-Pro 
Pro-Pro  Met-Val 
Thr-Gln  Lys-Ser 
K  +,  E4 §  Ars +/- 
Val-Pro 
Arg-Trp 
Most of the mutants were completely sequenced in the Vn region. 51 
contained mutations only at positions 58 and 59. Three,  the Arg-Leu 
and one each of the Arg-Arg and Arg-Ser mutants,  contained a fortui- 
tous Lys ~  Met change at VH codon 67 and were not used for further 
analysis. The number of independent isolates of some of the mutants are 
indicated in parentheses. 
" Amino acid combinations that have previously been observed among 
Ars-elicited in vivo antibodies. 
codons, respectively (Table 1). The presence of Cys in CDR2 
may often result  in global alteration  of V  region folding, 
leading to loss of both Ars binding and the E4 idiotope. Pro- 
line or Gly may locally alter the conformation of CDR2, 
often leading to loss of Ars binding but not idiotypy.  At po- 
sition 58,  16 of the 33 x+E4+Ars + (high Ars/K)  mutants 
contained Arg codons (Table 1). At position 59, 2 predomi- 
nant codons were observed; 8 Thr and 10 Arg codons. Five 
of these mutants contained Arg codons at both positions 58 
and 59. These frequencies were all much greater than expected 
from Arg and Thr codon frequencies  (Arg  =  9.8%;  Thr 
=  6.6% of all nontermination codons). Several other types 
of mutants were isolated multiple times from both libraries, 
many containing Arg at one position. The recurrent in vivo 
58 lie was not observed among the strong Ars-binding mu- 
tants but was seen in two of the Ars-  mutants.  Since con- 
trol mutants  with  Ile at position  58 bound  Ars with  high 
affinity (Table 2),  this may have resulted from biases in the 
random  mutation  procedure,  or inadequate  sample  size. 
The cplII coding sequences of 14 representative strong Ars- 
binding mutants were removed (see Fig. 1), allowing expres- 
sion  and  purification  of free  Fabs.  The  intrinsic  afffnities 
of these Fabs for Ars-Tyr were determined  via fluorescence 
quenching  and  are shown in Table 2.  The affinity of most 
of the mutants  was equal to or greater than  the wild-type 
(Thr-Lys) affinity. 4 of the 14 mutants displayed affinities equal 
to or greater than the Ile-Thr mutant. The rank order of these 
affinities was confirmed  using  a  less  sensitive ELISA  assay 
in which various concentrations of soluble Ars-Tyr were used 
to compete Fab binding to plate-bound Ars (data not shown). 
The abundance of Arg residues  observed,  an amino acid 
found frequently in CDRs of anti-DNA autoantibodies (10, 
11,  25),  taken together with previous data suggesting  that 
unmutated canonical antibodies display weak binding to dena- 
tured DNA (23), led us to measure the binding of the purified 
Table 2.  Intrinsic A.~nities of VH 58 and 59 Fab Mutants 
for Ars-N-acetyl-t-tyrosine 
58 + 59  Residues  K~ for Ars-Tyr (M-l) 
Controls 
Thr-Lys* (wild  type)  2.8  (2.7,2.8,2.9,3.0)  x  10  s 
Ile-Lys*  6.0  x  10  s 
Ile-Thr*  1.1  x  106 (8.9  x  105  ) 
Random  mutants 
Asp-Arg  1.6  (2.0)  x  105 
Ser-Arg  1.7  (1.8,1.8)  x  10  s 
Arg-Gly  1.8  (1.9)  x  10  s 
Arg-Ser  3.3  x  10  s 
Arg-Arg  3.5  (4.1)  x  10  s 
Ala-Pro  3.9  (3.9)  x  10  s 
Arg-Lys  4.1  x  105 
Arg-Thr  4.4  (4.8)  x  105 
Thr-Thr*  4.6  x  10  s 
Tyr-Thr  8.0  x  105 
Met-Val  1.0  x  106 
Arg-Ile  1.3  (1.3)  x  106 
Leu-Thr  1.6  (1.3,1.4,1.9)  x  106 
Pro-Arg  1.7  (1.4)  x  106 
When multiple affinities are shown for individual mutants (in parentheses), 
each value was obtained from an Fab preparation purified from an in- 
dependent culture of that mutant. Many of the individual values shown 
were derived from two independent quenching  analyses done on  the 
sample. 
* Amino acid combinations observed  among Ars-elicited  in vivo antibodies. 
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significant binding to denatured DNA (Table 3). Binding of 
eight of these mutants could be inhibited by low concentra- 
tions of Ars-Tyr, indicating that single or overlapping sites 
were responsible for both binding activities.  DNA binding 
of seven of the mutants was weakly competed by RNA, and 
Table 3.  Binding  of Vu 58 and 59 Fab Mutants to 
Heat-denatured DNA 
ssDNA 
58 + 59 Residues  binding*  Ars-TyrS  RNAII  dsDNA  I 
Controls 
Thr-Lys" 
(wild type) 
Ile-Lys* 
Ile-Thr * 
Random mutants 
Met-Val 
Leu-Thr 
Asp-Arg 
Thr-Thr* 
Tyr-Thr 
Arg-Gly  + / - 
Arg-Ser  + / - 
Ser-Arg  + 
Arg-Thr  + 
Arg-Ile  + 
Arg-Lys  + + 
Ala-Pro  + + 
Pro-Arg  + + 
Arg-Arg  + + + 
NI  NI  NI 
~30  15%  NI 
'~60  15%  NI 
8.5  28%  NI 
9.5  NI  NI 
6.5  51%  NI 
4.0  18%  11% 
5.5  16%  NI 
16.0  25%  NI 
* Amino acid combinations  previously  observed among  Ars-elicted  in vivo 
antibodies. 
* Rankings were based on: (a) ELISA signals three to four times above 
background at +/-  = 5/~g/ml; +  = 2.5/~g/ml; + +  = 1/~g/ml; 
+ + +  = 0.5/~g/ml; and (b) ability  of binding to be competed 50% 
by 10-50 ~g/ml soluble  denatured DNA at an Fab concentration  of 10 
#g/ml. A minus sign indicates no reproducible ELISA signal obtained 
over plate coated  without ssDNA at 10/Lg/ml  Fab. Binding  of the con- 
ventional anti-ss and dsDNA 3H9 mouse mAb (10) under these condi- 
tions is inhibited 50% by 3/~g/ml denatured DNA. 
S  The concentration  of Ars-Tyr (#M) that gave 50% inhibition  of bind- 
ing to plate immobilized  ssDNA at an Fab concentration  of 10/~g/ml. 
A concentration  of Ars-Tyr between 2 and 20/~M gives 50% inhibition 
to plate-bound Ars at this Fab concentration,  depending  on the intrinsic 
affinity of the particular Fab for Ars-Tyr. 
II The percent inhibition of binding to plate-immobilized  ssDNA ob- 
tained using 100/~g/ml soluble total yeast RNA or 740 #g/ml soluble 
native B cell hybridoma  DNA, at an Fab concentration  of 10/xg/ml. Bind- 
ing of 3H9 was inhibited 50% by 0.7/~g/ml native DNA and '~25% 
by 100 #g/ml RNA. 
NI, no inhibition detected. 
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binding of one of the mutants could be somewhat inhibited 
by native DNA.  Neither the Thr-Lys (wild-type) Fab nor 
the Ile-Lys or Ile-Thr (predominant in vivo) mutants displayed 
significant DNA  binding in  our  assays. Because  of their 
monovalence, it is likely that the Fabs that bound denatured 
DNA did so with significant affinity. Indeed, we found that 
Fabs  with Kas for Ars-Tyr of "~2  x  l0  s gave rise to Ars 
ELISA signals that were comparable to the signals obtained 
from the strongest DNA-binding Fabs on DNA plates. 
Discussion 
The bacteriophage Fab expression system relies on fold- 
ing  and  secretion  pathways  that  are  distinct  from  those 
of mammals. Certain mutant antibodies that could not be 
efficiently expressed by B lymphocytes might be expressed 
more readily as Fabs via the bacteriophage pathway, and vice 
versa. In the case of canonical anti-Ars antibodies, however, 
this is unlikely, as numerous single and multiple amino acid 
substitution combinations have been introduced into canon- 
ical antibodies in all three Via CDRs  (including positions 
58 and 59) with little or no effect on antibody production 
by B cell hybridomas (4, 21, 26, 27). Moreover, the only mu- 
tations we observed to ablate canonical Fab expression in the 
phage display format resulted in termination codons. 
The frequency of antigen loss variants due to random muta- 
genesis of VH CDR2 positions 58 and 59 is surprisingly low 
(Fig.  2).  This indicates that loss of V  region function due 
to mutations at 58 and 59 in vivo does not play a major role 
in the recurrent emergence of Ile and Thr as the predomi- 
nant amino acid substitutions at these positions. A previous 
random mutagenesis study of the CDR2 region of a T15 
idiotype expressing antiphosphorylcholine (PC) antibody re- 
vealed that a majority of mutants with two or more amino 
acid substitutions lacked affinity for PC  (28).  This study 
differed from ours in that mutations were randomly distributed 
throughout the length of CDR2. In addition, the T15 idio- 
type does not undergo affinity maturation (29),  suggesting 
that germline T15 antibodies may contain a binding site for 
PC that is already optimal. These data support the idea that 
the influence of somatic mutation on affinity  for antigen differs 
for different V regions, a parameter we have previously termed 
"adaptability" (30). 
A variety of amino acid combinations at Va CDIL2 po- 
sitions 58 and 59 result in increased  affinity for Ars (Table 
2).  The spectrum of these combinations stands in marked 
contrast to the limited number that are products of the so- 
matic mutation-affinity  maturation process acting on canonical 
V regions in vivo. Only 1 (Thr-Thr) of the 11 ex vivo amino 
acid combinations that displayed increased  affinity for Ars 
has been observed among in vivo mutants (combinations pre- 
viously observed in vivo are indicated by asterisks in Tables 
1-3). The recurrence of particular amino acid substitutions 
at 58 and 59 in vivo could be influenced by the type and 
frequency of mutations possible at these codons. The somatic 
mutation process displays a bias for introducing nucleotide 
transitions, may operate preferentially on smaU direct or in- 
verted repeats  and other small sequence  motifs, and seems to act with a preference for one of the DNA strands (1, 5, 
7).  It was previously suggested that the recurrent ACT 
ATT mutation to Ile at codon 58 in canonical VH genes may 
be templated by a small direct repeat sequence upstream of 
codon 58  in CDR2  (7). 
Another factor influencing amino acid recurrence at 58 and 
59 is the number of mutations required to produce a given 
amino acid substitution.  The somatic mutation process ap- 
pears mainly to introduce single nucleotide replacements, al- 
though whether such replacements are usually introduced 
in clusters is a subject of debate (5, 6, 31). The recurrent in 
vivo Thr-58 -* Ile and Lys-59 -* Thr substitutions require 
one nucleotide replacement each. Isoleucine was not observed 
among the high affinity ex vivo mutants at position 58, but 
Leu was observed, and, in combination with  Thr-59 gave 
rise to an affinity similar to the predominant in vivo Ile-Thr 
combination (Table 2). Mutation to Leu would require two 
nucleotide replacements in codon 58.  The low frequency of 
Leu and the recurrence of lie among in vivo mutants (1, 15) 
could therefore be due to restrictions on the mutation pro- 
cess at this codon. Many of the other high affinity ex vivo 
mutants also  contain amino acid substitutions  that  would 
require two nucleotide replacements in a codon to take place 
in vivo. 
Unmutated, canonical antibodies weakly bind denatured 
DNA, a property that is not displayed by canonical antibodies 
representative of the somatically mutated, Ars-selected memory 
repertoire (23).  We previously proposed that autoreactivity 
intrinsic to preimmune V  regions was lost upon their so- 
matic mutational alteration in vivo (23).  The data presented 
here suggest  that  this  conclusion is  probably  an  oversim- 
plification. The affinity for both Ars and DNA of canonical 
V regions is frequently enhanced by the same combinations 
of amino acid changes at VH positions 58  and 59.  Among 
the 480 ex vivo mutants screened, 5-10%  appeared, at the 
level of ELISA signal,  to bind better to Ars than the wild- 
type Fab. Of these,  nearly 80% had higher affinity for Ars, 
and >60%  had significant affinity for DNA. 
Fig. 3 presents a representation of the structure of the com- 
bining site of the canonical anti-Ars mAb 36-71, which con- 
tains the recurrent V~ 58Thr -* Ile and Lys-59 -* Thr sub- 
stitutions  (16). The side chains of the putative Ars contact 
residues in  V~  (Arg-96) and VH (Ash-35,  Trp-47,  Tyr-50, 
Set-99,  and Tyr-106) are shown, as are the side chains of V, 
Ile-58 and Thr-59.  The Ars hapten is shown in green and 
is positioned based on the results of previous site-filling and 
site-directed mutagenesis studies (16, 26,  27,  32).  It can be 
seen that Ile-58 is far from the binding pocket, and its side 
chain points away from this region. Threonine 59 is some- 
what closer to the bound hapten,  and its side chain points 
towards but not directly into the Ars-combining site. Given 
the orientation of the side chain of VH amino acid 58,  it is 
difficult to provide a simple structural explanation for the 
influence of this position on affinity for Ars and Ars con- 
jugates (for a more detailed discussion of this issue, see refer- 
ence 32). In contrast, the orientation of this side chain seems 
ideal to allow substitutions  that increase affinity for DNA 
while not dramatically affecting affinity for Ars. Indeed, six 
of the nine DNA-binding mutants contain Arg at this posi- 
tion,  and all but one of these mutants has  slightly higher 
affinity for Ars than the wild-type Fab. Arginine is routinely 
found in the CDRs  of anti-DNA antibodies derived from 
Figure 3.  Graphic representation of the combining  site 
of the canonical anti-Ars mAb 36-71. This image was 
generated as described  in Materials and Methods. The main 
chain atoms of the framework regions of VH and V~ are 
depicted as blue tubes. The main chain atoms of the Vu 
and VK CDR regions  are depicted  as orange  and red 
tubes, respectively. The side chains of the putative  Ars 
contact  residues  Arg-96  in CDR3  of VK,  Asn-35  in 
CDR1 of VH, Trp-47 in FW2 of VH, Tyr-50 in CDR2 
of VH, and Ser-99 and Tyr-106 in VH CDR3 are shown 
explicitly in yellow. Also shown in yellow are the side 
chains of Ile-58 and Thr-59. The Ars hapten is shown 
in green, and the phenyl ring is depicted in the orienta- 
tion presented in previous publications (16, 26, 27, 32), 
although docking procedures indicated that other orien- 
tations were no less favorable. The amino group that be- 
comes linked to Tyr on carrier proteins is present at the 
para position of the phenyl ring relative to the arsonate 
group and points away from the binding pocket. 
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other DNA-binding proteins (33). It has been suggested that 
this amino acid is particularly well suited for interaction with 
DNA because of its long and flexible side chain and its posi- 
tively charged guanidinium group, which contains many po- 
tential hydrogen bond donors and is planar with shared elec- 
trons, potentially allowing interaction with aromatic ring 
structures (34). The importance of Arg residues for the DNA- 
binding specificity of an anti-DNA mAb isolated  from an 
autoimmune mouse has been formally demonstrated via site- 
directed mutagenesis (34). 
The position 59 side chain, although apparently incapable 
of directly contacting the Ars hapten, might contact the Tyr 
side chain to which Ars is conjugated on carrier  proteins. 
Replacements of Lys-59 may alter antigen binding through 
changes in this interaction. Although the data are limited, 
it appears that large, positively charged side chains (Lys and 
Arg) slightly reduce Ars-binding affinity, while smaller, un- 
charged side chains (Ser, Thr, Val, Ile) often enhance affinity. 
The highly prevalent  Arg-Arg mutant has an increased 
affinity for Ars-Tyr compared with wild type, perhaps due, 
in part, to an electrostatic effect of creating a more positively 
charged binding environment for  the  negatively charged 
hapten. The Pro-Arg mutant has the highest affinity for Ars- 
Tyr and the second highest apparent affinity for DNA. The 
presence of Pro-58 probably significantly alters the confor- 
mation of the amino-terminal half of V~ CDR2,  which 
normally adopts a distorted B-sheet structure (16, 32), resulting 
in reorientation of the Arg-59 side chain. This reorientation 
apparently allows affinity enhancing interactions of Arg-59 
with both Ars-Tyr and DNA. Alteration of CDR2 confor- 
mation may also explain the enhanced Ars affinity and DNA 
binding of the Ala-Pro mutant. In general, however, altering 
VH CDR2 conformation destroys specificity for cognate an- 
tigen, as the majority of ex vivo mutants with Pro at either 
58 or 59 (or both) lack affinity  for Ars. 
Others have suggested that autoreactivity is an expected 
and frequent outcome of V region hypermutation (10-13). 
For example, antibodies to foreign antigens display a dearth 
of Arg residues in their CDKs (10), while anti-DNA anti- 
bodies characteristic  of systemic autoimmune diseases often 
contain multiple Arg residues in CDR regions (10, 11, 25). 
This difference has been interpreted to mean that, while Arg 
must arise frequently in CDKs during the maturation of the 
antibody response to foreign antigens, such mutants are ei- 
ther lost or selected against in normal individuals (10). 
Many of the ex vivo mutants with high affinity for both 
Ars and DNA contain Arg at positions 58, 59, or both. Muta- 
tional biases (see above) may limit substitutions to Arg at 
positions 58 and 59 in vivo. However, extensive amino acid 
diversity due to somatic mutation at codon 59 is observed 
among in vivo mutants (1, 15). In addition, our analysis shows 
that three (Cys, Gly, and Pro) of the seven amino acids (in- 
cluding Arg) that have not been observed at this position 
in vivo are often not compatible with specificity for Ars, al- 
though Pro in some contexts may increase both DNA and 
Ars binding (e.g., the Ala-Pro mutant). These data indicate 
that selective forces are largely responsible for the absence 
of Arg at position 59 among in vivo mutants. 
Our data are compatible with the concept that there is 
a "second window" of tolerance induction before formation 
of the memory B cell compartment (14). If, during the mu- 
tation-selection process, antiself and increased antiforeign an- 
tigen affinity were always produced by independent combi- 
nations of somatic mutations, positive selection forces alone 
might effectively eliminate the autoreactive mutants. How- 
ever, the "dual-specific" mutants, with increased affinity for 
both a foreign antigen (Ars) and a self antigen (DNA), our 
analysis indicates could be generated during the anti-Ars re- 
sponse could not be purged by positive selection alone, nega- 
tive selection would have to operate as well. Evidence that 
active negative selection can act on B lymphocytes expressing 
antibodies specific for DNA has been obtained from trans- 
genic mouse studies (35, 36). In the context of the germinal 
center, where most hypermutation and antigen selection is 
thought to take place, a relatively high concentration of ex- 
tracellular nucleic acid may be available due to the cell death 
that takes place in this microenvironment (37). Direct sup- 
port for this hypothesis requires the demonstration that so- 
matic mutations that result in simultaneous increases in affinity 
for Ars and DNA take place during antigen-driven B cell 
differentiation in vivo. 
A combination of positive and negative selection forces 
operating on rapidly mutating B cells in germinal centers 
would result in the specificity maturation of the immune re- 
sponse. The high specificity of the antibodies that resulted 
would maximize the sensitivity of the memory B cell com- 
partment to low concentrations of foreign antigen while 
minimizing the chance of development of autoimmunity. Most 
ex vivo antibody mutation-selection strategies rely on increased 
affinity for cognate antigen as a measure of antibodies that 
will work better in therapeutic and diagnostic contexts (38). 
Our data suggest that this assumption is ill-founded. Under 
the influence of only antigen affinity-based positive selection 
forces, antibodies with increased affinity for both foreign and 
autoantigens might often arise. 
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